Phibro Animal Health
PAHC
33.29
-0.79
-2.32%
Phibro Animal Health
US · PAHC
#2966 by market cap
Listed 1970
33.29
-0.79
-2.32%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Quant vs Street three independent views, side by side
StockVane factor grade
A
Momentum strategy signal
Sell
Analyst consensus
Hold
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Analyst consensus 2 analysts
Hold
Avg price target 45.00 +35.2%
Price target rangecurrent 33.29
Low35.00
Avg45.00
High55.00
Buy 50%
Hold 0%
Sell 50%
Recent ratings (16)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-10-16 | J.P. Morgan | -- | Buy | 55.00 |
| 2026-09-01 | J.P. Morgan | -- | Buy | 55.00 |
| 2026-08-27 | BofA Securities | -- | Sell | 35.00 |
| 2026-08-25 | J.P. Morgan | -- | Buy | 58.00 |
| 2026-07-28 | BofA Securities | -- | Sell | -- |
| 2026-06-12 | J.P. Morgan | -- | Buy | -- |
| 2026-05-14 | Citi | -- | Hold | 44.00 |
| 2026-05-13 | Citi | -- | Hold | 44.00 |
| 2026-04-16 | Citi | -- | Hold | 62.00 |
| 2026-04-15 | Citi | -- | Hold | 62.00 |
| 2026-02-09 | J.P. Morgan | -- | Buy | 58.00 |
| 2026-02-05 | BofA Securities | -- | Sell | 38.00 |
| 2026-02-04 | BofA Securities | -- | Sell | 32.00 |
| 2026-01-30 | BofA Securities | -- | Sell | 32.00 |
| 2025-11-07 | Morgan Stanley | -- | Hold | 45.00 |
| 2025-11-07 | J.P. Morgan | -- | Buy | 50.00 |
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2027/Q1 | 2026-11-04 | After close | ±12.33% | -10.22% (in line) |
| 2026/Q4 | 2026-08-27 | After close | ±9.05% | +3.63% (in line) |
| 2026/Q3 | 2026-05-06 | After close | ±11.91% | -26.22% (beat) |
| 2026/Q2 | 2026-02-04 | After close | ±12.16% | +21.95% (beat) |
| 2026/Q1 | 2025-11-05 | After close | ±12.84% | +4.59% (in line) |
| 2025/Q4 | 2025-08-27 | After close | ±16.21% | +19.44% (beat) |
| 2025/Q3 | 2025-05-07 | After close | -- | +14.75% |
| 2025/Q2 | 2025-02-05 | After close | ±12.70% | +9.88% (in line) |
| 2025/Q1 | 2024-11-06 | After close | ±6.50% | +1.78% (in line) |
| 2024/Q4 | 2024-08-28 | After close | ±15.32% | +3.17% (in line) |
| 2024/Q3 | 2024-05-08 | After close | ±13.57% | +3.03% (in line) |
| 2024/Q2 | 2024-02-07 | After close | -- | +7.40% |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Phibro Animal Health discussion 0 comments